Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 20.57 Million USD | 4.78% |
| 2021 | 19.63 Million USD | 60.12% |
| 2020 | 12.26 Million USD | -16.63% |
| 2019 | 14.7 Million USD | 3.58% |
| 2018 | 14.19 Million USD | 125.72% |
| 2017 | 6.29 Million USD | -2.96% |
| 2016 | 6.48 Million USD | -76.83% |
| 2015 | 27.97 Million USD | 548.25% |
| 2014 | 4.31 Million USD | -82.95% |
| 2013 | 25.3 Million USD | 262.48% |
| 2012 | 6.98 Million USD | -19.4% |
| 2011 | 8.66 Million USD | -22.67% |
| 2010 | 11.2 Million USD | -31.29% |
| 2009 | 16.3 Million USD | -52.52% |
| 2008 | 34.33 Million USD | -14.33% |
| 2007 | 40.07 Million USD | -3.79% |
| 2006 | 41.65 Million USD | 32.28% |
| 2005 | 31.49 Million USD | 56.73% |
| 2004 | 20.09 Million USD | -11.32% |
| 2003 | 22.65 Million USD | 31.66% |
| 2002 | 17.2 Million USD | -41.12% |
| 2001 | 29.22 Million USD | -30.83% |
| 2000 | 42.25 Million USD | 18.78% |
| 1999 | 35.57 Million USD | -10.4% |
| 1998 | 39.7 Million USD | -27.95% |
| 1997 | 55.1 Million USD | -13.23% |
| 1996 | 63.5 Million USD | -0.47% |
| 1995 | 63.8 Million USD | 89.32% |
| 1994 | 33.7 Million USD | 22.68% |
| 1993 | 27.47 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 21.55 Million USD | 4.78% |
| 2023 Q1 | 20.57 Million USD | 0.0% |
| 2023 Q3 | 19.84 Million USD | -7.93% |
| 2022 Q2 | 19.23 Million USD | 1.14% |
| 2022 Q1 | 19.01 Million USD | -3.16% |
| 2022 Q4 | 20.57 Million USD | 1.4% |
| 2022 Q3 | 20.28 Million USD | 5.5% |
| 2022 FY | 20.57 Million USD | 4.78% |
| 2021 Q2 | 19.62 Million USD | 75.02% |
| 2021 Q4 | 19.63 Million USD | -4.22% |
| 2021 FY | 19.63 Million USD | 60.12% |
| 2021 Q1 | 11.21 Million USD | -8.55% |
| 2021 Q3 | 20.49 Million USD | 4.46% |
| 2020 Q2 | 15.21 Million USD | -3.49% |
| 2020 Q1 | 15.76 Million USD | 7.19% |
| 2020 Q3 | 15.09 Million USD | -0.81% |
| 2020 Q4 | 12.26 Million USD | -18.75% |
| 2020 FY | 12.26 Million USD | -16.63% |
| 2019 Q2 | 16.92 Million USD | 8.43% |
| 2019 Q1 | 15.61 Million USD | 9.95% |
| 2019 FY | 14.7 Million USD | 3.58% |
| 2019 Q4 | 14.7 Million USD | -11.26% |
| 2019 Q3 | 16.57 Million USD | -2.09% |
| 2018 Q4 | 14.19 Million USD | -26.93% |
| 2018 FY | 14.19 Million USD | 125.72% |
| 2018 Q2 | 16.24 Million USD | 164.69% |
| 2018 Q1 | 6.13 Million USD | -2.43% |
| 2018 Q3 | 19.43 Million USD | 19.61% |
| 2017 Q2 | 5.68 Million USD | -31.58% |
| 2017 Q1 | 8.31 Million USD | 28.24% |
| 2017 FY | 6.29 Million USD | -2.96% |
| 2017 Q4 | 6.29 Million USD | -1.18% |
| 2017 Q3 | 6.36 Million USD | 11.93% |
| 2016 Q3 | 10.19 Million USD | -44.43% |
| 2016 Q1 | 22.46 Million USD | -23.5% |
| 2016 Q2 | 18.35 Million USD | -18.32% |
| 2016 FY | 6.48 Million USD | -76.83% |
| 2016 Q4 | 6.48 Million USD | -36.43% |
| 2015 Q3 | 7.1 Million USD | -15.48% |
| 2015 FY | 27.97 Million USD | 548.25% |
| 2015 Q2 | 8.41 Million USD | -9.66% |
| 2015 Q1 | 9.3 Million USD | 251.28% |
| 2015 Q4 | 29.36 Million USD | 313.2% |
| 2014 Q4 | 2.65 Million USD | -27.08% |
| 2014 FY | 4.31 Million USD | -82.95% |
| 2014 Q1 | 4.31 Million USD | -16.31% |
| 2014 Q3 | 3.63 Million USD | -24.15% |
| 2014 Q2 | 4.79 Million USD | 11.03% |
| 2013 Q4 | 5.15 Million USD | -14.12% |
| 2013 Q3 | 6 Million USD | -6.57% |
| 2013 Q2 | 6.42 Million USD | -7.96% |
| 2013 Q1 | 6.98 Million USD | -11.17% |
| 2013 FY | 25.3 Million USD | 262.48% |
| 2012 Q2 | 7.89 Million USD | -8.87% |
| 2012 Q3 | 9.01 Million USD | 14.16% |
| 2012 Q4 | 7.86 Million USD | -12.78% |
| 2012 FY | 6.98 Million USD | -19.4% |
| 2012 Q1 | 8.66 Million USD | -20.55% |
| 2011 Q2 | 9.74 Million USD | -13.03% |
| 2011 FY | 8.66 Million USD | -22.67% |
| 2011 Q4 | 10.9 Million USD | 21.77% |
| 2011 Q3 | 8.95 Million USD | -8.09% |
| 2011 Q1 | 11.2 Million USD | -14.04% |
| 2010 FY | 11.2 Million USD | -31.29% |
| 2010 Q2 | 12.69 Million USD | -22.16% |
| 2010 Q1 | 16.3 Million USD | -26.86% |
| 2010 Q4 | 13.03 Million USD | 11.34% |
| 2010 Q3 | 11.7 Million USD | -7.79% |
| 2009 Q1 | 34.33 Million USD | -10.83% |
| 2009 FY | 16.3 Million USD | -52.52% |
| 2009 Q2 | 31.69 Million USD | -7.69% |
| 2009 Q3 | 29.85 Million USD | -5.82% |
| 2009 Q4 | 22.28 Million USD | -25.33% |
| 2008 Q4 | 38.5 Million USD | 1.03% |
| 2008 Q2 | 38.13 Million USD | -4.85% |
| 2008 Q1 | 40.07 Million USD | -9.6% |
| 2008 Q3 | 38.11 Million USD | -0.06% |
| 2008 FY | 34.33 Million USD | -14.33% |
| 2007 FY | 40.07 Million USD | -3.79% |
| 2007 Q1 | 41.65 Million USD | 0.91% |
| 2007 Q2 | 42.72 Million USD | 2.58% |
| 2007 Q3 | 43.53 Million USD | 1.87% |
| 2007 Q4 | 44.33 Million USD | 1.85% |
| 2006 Q3 | 26.84 Million USD | -11.91% |
| 2006 Q1 | 31.49 Million USD | -9.7% |
| 2006 FY | 41.65 Million USD | 32.28% |
| 2006 Q2 | 30.47 Million USD | -3.22% |
| 2006 Q4 | 41.28 Million USD | 53.76% |
| 2005 Q2 | 17.68 Million USD | -12.0% |
| 2005 Q4 | 34.87 Million USD | -1.61% |
| 2005 Q1 | 20.09 Million USD | -15.19% |
| 2005 FY | 31.49 Million USD | 56.73% |
| 2005 Q3 | 35.44 Million USD | 100.49% |
| 2004 Q4 | 23.69 Million USD | 14.89% |
| 2004 Q2 | 18.6 Million USD | -17.9% |
| 2004 FY | 20.09 Million USD | -11.32% |
| 2004 Q1 | 22.65 Million USD | 4.99% |
| 2004 Q3 | 20.62 Million USD | 10.84% |
| 2003 Q1 | 17.2 Million USD | -13.65% |
| 2003 Q3 | 26.27 Million USD | 42.33% |
| 2003 FY | 22.65 Million USD | 31.66% |
| 2003 Q4 | 21.58 Million USD | -17.85% |
| 2003 Q2 | 18.45 Million USD | 7.26% |
| 2002 Q4 | 19.92 Million USD | -20.23% |
| 2002 Q1 | 29.22 Million USD | -17.21% |
| 2002 Q2 | 25.29 Million USD | -13.44% |
| 2002 FY | 17.2 Million USD | -41.12% |
| 2002 Q3 | 24.98 Million USD | -1.25% |
| 2001 Q4 | 35.3 Million USD | -8.44% |
| 2001 Q1 | 42.25 Million USD | -7.05% |
| 2001 Q2 | 43.06 Million USD | 1.93% |
| 2001 FY | 29.22 Million USD | -30.83% |
| 2001 Q3 | 38.55 Million USD | -10.47% |
| 2000 FY | 42.25 Million USD | 18.78% |
| 2000 Q3 | 39.12 Million USD | 5.55% |
| 2000 Q4 | 45.45 Million USD | 16.2% |
| 2000 Q2 | 37.06 Million USD | 4.19% |
| 2000 Q1 | 35.57 Million USD | -4.12% |
| 1999 FY | 35.57 Million USD | -10.4% |
| 1999 Q2 | 36.8 Million USD | -7.3% |
| 1999 Q3 | 35.3 Million USD | -4.08% |
| 1999 Q4 | 37.1 Million USD | 5.1% |
| 1999 Q1 | 39.7 Million USD | -13.7% |
| 1998 Q2 | 50.8 Million USD | -7.8% |
| 1998 Q4 | 46 Million USD | -7.44% |
| 1998 FY | 39.7 Million USD | -27.95% |
| 1998 Q1 | 55.1 Million USD | -4.17% |
| 1998 Q3 | 49.7 Million USD | -2.17% |
| 1997 FY | 55.1 Million USD | -13.23% |
| 1997 Q4 | 57.5 Million USD | -5.27% |
| 1997 Q1 | 63.5 Million USD | 6.54% |
| 1997 Q3 | 60.7 Million USD | -1.94% |
| 1997 Q2 | 61.9 Million USD | -2.52% |
| 1996 Q3 | 66.2 Million USD | 1.22% |
| 1996 Q4 | 59.6 Million USD | -9.97% |
| 1996 FY | 63.5 Million USD | -0.47% |
| 1996 Q1 | 63.8 Million USD | 2.24% |
| 1996 Q2 | 65.4 Million USD | 2.51% |
| 1995 Q4 | 62.4 Million USD | 60.12% |
| 1995 FY | 63.8 Million USD | 89.32% |
| 1995 Q3 | 38.97 Million USD | 17.1% |
| 1995 Q1 | 33.7 Million USD | 0.0% |
| 1995 Q2 | 33.28 Million USD | -1.25% |
| 1994 FY | 33.7 Million USD | 22.68% |
| 1993 FY | 27.47 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -1521.179% |
| Arrayit Corporation | 1 Million USD | -1956.476% |
| Atlantic International Corp. | 4.43 Million USD | -363.731% |
| Biocept, Inc. | 30.87 Million USD | 33.363% |
| Bioqual, Inc. | 56.58 Million USD | 63.645% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -8770.17% |
| DermTech, Inc. | 121.93 Million USD | 83.127% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.508% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -15.723% |
| iMD Companies, Inc. | 190.13 Thousand USD | -10719.968% |
| IDenta Corp. | 1.52 Million USD | -1245.262% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -57.997% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -149.309% |
| InVitro International | 1.53 Million USD | -1241.113% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 23.345% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -889725.346% |
| Medical Imaging Corp. | 4.19 Million USD | -390.806% |
| NovelStem International Corp. | 2.25 Million USD | -812.501% |
| Optigenex Inc. | 1.88 Million USD | -989.492% |
| PharmChem, Inc. | 2.76 Million USD | -643.892% |
| Proteome Sciences plc | 14.58 Million USD | -41.044% |
| Response Genetics, Inc | 48.88 Million USD | 57.915% |
| RushNet, Inc. | 6.04 Million USD | -240.18% |
| ScreenPro Security Inc. | 1.26 Million USD | -1531.0% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -4254.733% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -2836.231% |
| Todos Medical Ltd. | 15.26 Million USD | -34.753% |